Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Orbimed Genesis Gp Llc
Relationship:   Director, 10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   14    
Direct Shares   0    

Indirect Shares

   58,578,510      
Direct Value   $0    

Indirect Value

   $284,227,743      
Total Shares   58,578,510      
Total Value   $284,227,743      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Keros Therapeutics, Inc. KROS Director 2020-04-13 0 2020-04-13 1,119,812    Premium*  
            Scpharmaceuticals Inc. SCPH 10% Owner 2020-05-21 0 2022-11-25 5,559,528    Premium*  
            Logicbio Therapeutics, Inc. LOGC Director, 10% Owner 2020-10-01 0 2020-10-01 296,296    Premium*  
            Galecto Inc. GLTO Director, 10% Owner 2020-11-02 0 2020-11-02 1,031,811    Premium*  
            Edgewise Therapeutics, Inc. EWTX Director, 10% Owner 0 2024-01-23 14,756,096    Premium*  
            Ikena Oncology, Inc. IKNA Director 2021-03-30 0 2023-08-04 7,928,543    Premium*  
            Alpine Immune Sciences Inc ALPN Director 2021-09-17 0 2024-01-11 2,680,496    Premium*  
            Theseus Pharmaceuticals, Inc. THRX Director, 10% Owner 2021-10-12 0 2024-02-14 0    Premium*  
            Janux Therapeutics, Inc. JANX Director 2021-12-16 0 2021-12-29 231,098    Premium*  
            Sierra Oncology Inc SRRA Director, 10% Owner 2022-01-26 0 2022-01-26 226,704    Premium*  
            Pmv Pharmaceuticals, Inc. PMVP 10% Owner 2022-05-26 0 2023-11-22 6,475,291    Premium*  
            Terns Pharmaceuticals, Inc. TERN Director, 10% Owner 2022-08-16 0 2022-12-23 7,619,135    Premium*  
            Disc Medicine, Inc IRON Director 2023-12-18 0 2023-12-18 1,702,237    Premium*  
            Enliven Therapeutics Ord Shs ELVN Director, 10% Owner 2023-02-23 0 2023-05-17 8,951,463    Premium*  
* Premium Members only  

Records found :    56         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EWTX Edgewise Therapeutics, In... Director   –       •       •   2021-03-25 3 IO $0.00 $0 I/I 0 316,920 -
IRON Disc Medicine, Inc Director   –       •      –    2023-12-14 4 S $57.73 $11,546 I/I (200) 727,807 0 %
IRON Disc Medicine, Inc Director   –       •      –    2023-12-18 4 S $59.24 $102,130 D/D (1,724) 0 0 %
IRON Disc Medicine, Inc Director   –       •      –    2023-12-18 4 OE $38.00 $65,512 D/D 1,724 1,724 0 -
ELVN Enliven Therapeutics Ord ... Director   –       •       •   2023-05-17 4 OE $4.28 $9,095 I/I 2,125 8,663,349 0 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-11 4 B $9.81 $89,319 I/I 8,500 16,348,018 2.25 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-19 4 B $9.97 $114,864 I/I 11,521 16,395,756 2.25 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-13 4 B $9.43 $163,328 I/I 17,320 16,384,235 2.25 -
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-12 4 B $10.06 $190,104 I/I 18,897 16,366,915 2.25 -
IKNA Ikena Oncology, Inc. Director   –       •      –    2022-06-23 4 S $3.71 $86,884 I/I (23,419) 1,936,097 0 -
PMVP Pmv Pharmaceuticals, Inc. 10% Owner   –       –       •   2022-05-26 4 S $15.93 $418,210 I/I (26,253) 87,786 0 -
IRON Disc Medicine, Inc Director   –       •      –    2023-12-12 4 S $60.16 $1,642,368 I/I (27,300) 295,605 0 %
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-20 4 B $9.95 $348,250 I/I 35,000 16,430,756 2.25 -
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-29 4 S $20.30 $820,120 I/I (40,400) 231,098 0 -
IKNA Ikena Oncology, Inc. Director   –       •      –    2022-06-22 4 S $3.55 $237,161 I/I (66,806) 1,912,678 0 -
PMVP Pmv Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-11-22 4 S $2.23 $195,763 I/I (87,786) 0 0 -
IRON Disc Medicine, Inc Director   –       •      –    2023-12-13 4 S $58.56 $6,248,352 I/I (106,700) 281,505 0 %
IRON Disc Medicine, Inc Director   –       •       •   2023-02-15 4 B $23.00 $2,500,008 I/I 108,696 299,205 2.25 %
THRX Theseus Pharmaceuticals, ... Director   –       •       •   2022-01-21 4 B $9.97 $1,115,603 I/I 111,896 16,542,652 2.25 -
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-21 4 S $19.00 $2,268,600 I/I (119,400) 234,798 0 -
TERN Terns Pharmaceuticals, In... Director   –       •       •   2022-12-23 4 B $7.25 $1,000,000 I/I 137,931 4,882,854 2.25 %
EWTX Edgewise Therapeutics, In... Director   –       •       •   2022-05-18 4 B $7.21 $994,980 I/I 138,000 13,497,456 2.25 -
ALPN Alpine Immune Sciences In... Director   –       •      –    2024-01-11 4 OE $12.74 $1,850,498 I/I 145,251 2,416,181 0 -
IKNA Ikena Oncology, Inc. Director   –       •      –    2023-08-04 4/A A $0.00 $0 I/I 153,121 5,582,144 0 -
IKNA Ikena Oncology, Inc. Director   –       •      –    2023-08-04 4 A $0.00 $0 I/I 153,121 2,251,218 0 -
  56  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us